In AD pathology regulation, flavonoids inhibit β-secretase (β-site amyloid precursor protein cleaving enzyme, BACE1) activity to reduce Aβ generation while promoting insulin-degrading enzyme expression to accelerate Aβ clearance (50). This evidence concerns the gene BACE1 and Alzheimer disease.